|
[1]
|
Liberopoulos, E., Siamopoulos, K. and Elisaf, M. (2004) Apolipoprotein E and Renal Disease. American Journal of Kidney Diseases, 43, 223-233. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Saito, T., Ishigaki, Y., Oikawa, S. and Yamamoto, T.T. (2002) Etiological Significance of Apolipoprotein E Mutations in Lipoprotein Glomerulopathy. Trends in Cardiovascular Medicine, 12, 67-70. [Google Scholar] [CrossRef]
|
|
[3]
|
Saito, T., et al. (1999) Lipoprotein Glomerulopathy: Renal Lipidosis Induced by Novel Apolipoprotein E Variants. Nephron, 83, 193-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
王秋媛. 脂蛋白肾病发病机制研究进展[J]. 国际泌尿系统杂志, 2014, 34(3): 414-419.
|
|
[5]
|
Rall Jr., S.C., Weisgraber, K.H. and Mahley, R.W. (1982) The Complete Amino Acid Sequence. The Journal of Biological Chemistry, 257, 4171-4178.
|
|
[6]
|
Oikawa, S., Matsunaga, A., Satio, T., et al. (1997) Apolipoprotein E Sendai (Arginine 145 Proline): A New Variant Associated with Lipoprotein Glomerulopathy. Journal of the American Society of Nephrology, 8, 820-823.
|
|
[7]
|
潘永利, 陈育青, 张宏, 等. 四例脂蛋白肾病患者载脂蛋白E基因突变筛查[J]. 中华肾脏病杂志, 2006, 8(1): 449-453.
|
|
[8]
|
Wu, H., Yang, Y. and Hu, Z. (2018) The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T > C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy. Journal of Atherosclerosis and Thrombosis, 25, 733-740. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Kanamaru, Y. (2002) Chronic Graft-versus-Host Autoimmune Disease in Fc Receptor Chain-Deficient Mice Results in Lipoprotein Glomerulopathy. Journal of the American Society of Nephrology, 13, 1527-1533. [Google Scholar] [CrossRef]
|
|
[10]
|
Miyahara, Y., et al. (2012) Scavenger Receptor Expressions in the Kidneys of Mice with Lipoprotein Glomerulopathy. Clinical and Experimental Nephrology, 16, 115-121. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zhang, X., Hong, L.Z., Jun, L.S., et al. (2008) Successful Treatment of Patients with Lipoprotein Glomerulopathy by Protein A Immunoadsorption: A Pilot Study. Nephrology Dialysis Transplantation, 24, 864-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Andrews, P.A., O’Donnell, P.J., Dilly, S.A., et al. (1997) Recurrence of Lipoprotein Glomerulopathy after Renal Transplantation. Nephrology Dialysis Transplantation, 12, 2442-2444. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Shimizu, M., Ohno, T., Kimoto, H., Hosono, S. and Nozawa, M. (2001) A Newborn Infant with Lipoprotein Glomerulopathy Asso-ciated with Congenital Nephrotic Syndrome. Pediatrics International, 43, 78-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Usui, R., Takahashi, M., et al. (2016) Five-Year Fol-low-Up of a Case of Lipoprotein Glomerulopathy with APOE Kyoto Mutation. CEN Case Reports, 5, 148-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hu, Z.X., Huang, S.M., Wu, Y., et al. (2014) Hereditary Features, Treatment, and Prognosis of the Lipoprotein Glomerulopathy in Patients with the APOE Kyoto Mutation. Kidney In-ternational, 85, 416-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
杨聚荣, 何娅妮, 林利容, 等. 免疫吸附治疗重症脂蛋白肾病1例报道[J]. 中国血液净化, 2006, 11(5): 816-818.
|
|
[17]
|
Li, W., Wang, Y., Han, Z., et al. (2014) Apolipoprotein E Mutation and Double Filtration Plasmapheresis Therapy on a New Chinese Patient with Lipoprotein Glomerulopathy. Kidney and Blood Pressure Research, 39, 330-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
晋中恒, 郭术莲, 蒋松, 等. 脂蛋白肾病治验2例[J]. 临床合理用药, 2013, 6(3): 132-133.
|